Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Surfactant found in coconut oil.
Diamidine; ACE2 activator, DNA polymerase inhib...
BK K+ channel and L-type Ca2+ channel blocker.<...
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
AurKA/B inhibitor.
EGFR inhibitor.
Inert clozapine analog, activates specialized G...
Polyphenol found in many plants and foods.
Protein translation inhibitor, peptidyl transfe...
ALK inhibitor.
Aminoquinoline, binds heme, causes cell lysis.<...
Fermentation impurity
Fibrate; PPARα agonist.
MAO-A/B inhibitor.
Oltipraz analog, salivary gland secretion enhan...
Aldose reductase inhibitor.
BHA derivative.
Non-specific caspase inhibitor used to prevent ...
Corticosteroid
Bipyridamine toxin.